| 1 | [SID85209669] | Active | | | Ligands of bioamine (Class A) GPCRs [AID2062, Type: other] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 85209669 | | CID | 5032 | | Outcome | Active | | BioAssay | Ligands of bioamine (Class A) GPCRs | | AID | 2062 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID85789554] | Inactive | | | Fluorescence Cell-Based Primary HTS to Identify Reactive Oxygen Species Inducers in Cancer Cells Measured in Cell-Based System Using Plate Reader and Imaging Combination - 2044-01_Activator_SinglePoint_HTS_Activity [AID624156, Type: screening] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 85789554 | | CID | 5032 | | Outcome | Inactive | | BioAssay | Fluorescence Cell-Based Primary HTS to Identify Reactive Oxygen Species Inducers in Cancer Cells Measured in Cell-Based System Using Plate Reader and Imaging Combination - 2044-01_Activator_SinglePoint_HTS_Activity | | AID | 624156 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID85789554] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 [AID2241, Type: screening] | Chain A, Human Bcl2-A1 In Complex With Bim-Bh3 Peptide [gi:167013344] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 85789554 | | CID | 5032 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 | | AID | 2241 | | BioAssay type | screening | | Target | Chain A, Human Bcl2-A1 In Complex With Bim-Bh3 Peptide [gi:167013344] | | PubMed | | | Data Table |  |
|
| 4 | [SID85789554] | Inactive | | | SMM ID4 Measured in Biochemical System Using Small Molecule MicroArray - 2128-01_Other_SinglePoint_HTS_Activity [AID624137, Type: screening] | Id4 [Homo sapiens] [gi:881546] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 85789554 | | CID | 5032 | | Outcome | Inactive | | BioAssay | SMM ID4 Measured in Biochemical System Using Small Molecule MicroArray - 2128-01_Other_SinglePoint_HTS_Activity | | AID | 624137 | | BioAssay type | screening | | Target | Id4 [Homo sapiens] [gi:881546] | | PubMed | | | Data Table |  |
|
| 5 | [SID85789554] | Inactive | | | Development of IDH1/2 inhibitors (CTD2project) Measured in Biochemical System Using Plate Reader - 2107-01_Inhibitor_SinglePoint_HTS_Activity [AID624101, Type: screening] | Isocitrate dehydrogenase 1 (NADP+), soluble [Homo sapiens] [gi:62203298] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 85789554 | | CID | 5032 | | Outcome | Inactive | | BioAssay | Development of IDH1/2 inhibitors (CTD2project) Measured in Biochemical System Using Plate Reader - 2107-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 624101 | | BioAssay type | screening | | Target | Isocitrate dehydrogenase 1 (NADP+), soluble [Homo sapiens] [gi:62203298] | | PubMed | | | Data Table |  |
|
| 6 | [SID85789554] | Inactive | | | Development of IDH1/2 inhibitors (CTD2project) Measured in Biochemical System Using Plate Reader - 2107-01_Inhibitor_SinglePoint_HTS_Activity [AID624101, Type: screening] | Isocitrate dehydrogenase 1 (NADP+), soluble [Homo sapiens] [gi:62203298] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 85789554 | | CID | 5032 | | Outcome | Inactive | | BioAssay | Development of IDH1/2 inhibitors (CTD2project) Measured in Biochemical System Using Plate Reader - 2107-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 624101 | | BioAssay type | screening | | Target | Isocitrate dehydrogenase 1 (NADP+), soluble [Homo sapiens] [gi:62203298] | | PubMed | | | Data Table |  |
|
| 7 | [SID85789554] | Inactive | | | Development of IDH1/2 inhibitors (CTD2project) Measured in Biochemical System Using Plate Reader - 2107-01_Inhibitor_SinglePoint_HTS_Activity [AID624101, Type: screening] | Isocitrate dehydrogenase 1 (NADP+), soluble [Homo sapiens] [gi:62203298] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 85789554 | | CID | 5032 | | Outcome | Inactive | | BioAssay | Development of IDH1/2 inhibitors (CTD2project) Measured in Biochemical System Using Plate Reader - 2107-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 624101 | | BioAssay type | screening | | Target | Isocitrate dehydrogenase 1 (NADP+), soluble [Homo sapiens] [gi:62203298] | | PubMed | | | Data Table |  |
|
| 8 | [SID85789554] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of MITF [AID2240, Type: screening] | microphthalmia-associated transcription factor isoform 1 [Homo sapiens] [gi:38156699] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 85789554 | | CID | 5032 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of MITF | | AID | 2240 | | BioAssay type | screening | | Target | microphthalmia-associated transcription factor isoform 1 [Homo sapiens] [gi:38156699] | | PubMed | | | Data Table |  |
|
| 9 | [SID85789554] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of MITF [AID2240, Type: screening] | microphthalmia-associated transcription factor isoform 1 [Homo sapiens] [gi:38156699] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 85789554 | | CID | 5032 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of MITF | | AID | 2240 | | BioAssay type | screening | | Target | microphthalmia-associated transcription factor isoform 1 [Homo sapiens] [gi:38156699] | | PubMed | | | Data Table |  |
|
| 10 | [SID85789554] | Inactive | | | NSD2 Inhibitors Measured in Biochemical System Using Plate Reader - 2115-01_Inhibitor_SinglePoint_HTS_Activity [AID624260, Type: screening] | WHSC1 gene product [Homo sapiens] [gi:109633019] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 85789554 | | CID | 5032 | | Outcome | Inactive | | BioAssay | NSD2 Inhibitors Measured in Biochemical System Using Plate Reader - 2115-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 624260 | | BioAssay type | screening | | Target | WHSC1 gene product [Homo sapiens] [gi:109633019] | | PubMed | | | Data Table |  |
|
| 11 | [SID85789554] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33 [AID2330, Type: screening] | serine/threonine kinase 33 [Homo sapiens] [gi:12830367] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 85789554 | | CID | 5032 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33 | | AID | 2330 | | BioAssay type | screening | | Target | serine/threonine kinase 33 [Homo sapiens] [gi:12830367] | | PubMed | | | Data Table |  |
|
| 12 | [SID85789554] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33 [AID2330, Type: screening] | serine/threonine kinase 33 [Homo sapiens] [gi:12830367] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 85789554 | | CID | 5032 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33 | | AID | 2330 | | BioAssay type | screening | | Target | serine/threonine kinase 33 [Homo sapiens] [gi:12830367] | | PubMed | | | Data Table |  |
|
| 13 | [SID85789554] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33 [AID2330, Type: screening] | serine/threonine kinase 33 [Homo sapiens] [gi:12830367] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 85789554 | | CID | 5032 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33 | | AID | 2330 | | BioAssay type | screening | | Target | serine/threonine kinase 33 [Homo sapiens] [gi:12830367] | | PubMed | | | Data Table |  |
|
| 14 | [SID74582] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain [AID165, Type: other] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 74582 | | CID | 5032 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain | | AID | 165 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID74582] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the bub3 strain [AID167, Type: other] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 74582 | | CID | 5032 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the bub3 strain | | AID | 167 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID74582] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain [AID175, Type: other] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 74582 | | CID | 5032 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain | | AID | 175 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID74582] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model P1534 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice [AID316, Type: other] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 74582 | | CID | 5032 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model P1534 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 316 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID74582] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Sarcoma 180 (subcutaneous) in Swiss mice [AID342, Type: other] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 74582 | | CID | 5032 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Sarcoma 180 (subcutaneous) in Swiss mice | | AID | 342 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID74582] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain [AID161, Type: other] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 74582 | | CID | 5032 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain | | AID | 161 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID74582] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain [AID157, Type: other] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 74582 | | CID | 5032 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain | | AID | 157 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID74582] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the rad50 strain [AID155, Type: other] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 74582 | | CID | 5032 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the rad50 strain | | AID | 155 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID439794] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the rad50 strain [AID155, Type: other] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 439794 | | CID | 5032 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the rad50 strain | | AID | 155 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID439794] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the bub3 strain [AID167, Type: other] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 439794 | | CID | 5032 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the bub3 strain | | AID | 167 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID439794] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain [AID175, Type: other] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 439794 | | CID | 5032 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain | | AID | 175 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID439794] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice [AID248, Type: other] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 439794 | | CID | 5032 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 248 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID439794] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice [AID256, Type: other] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 439794 | | CID | 5032 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 256 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID439794] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice [AID330, Type: other] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 439794 | | CID | 5032 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 330 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID439794] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain [AID157, Type: other] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 439794 | | CID | 5032 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain | | AID | 157 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID439794] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain [AID161, Type: other] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 439794 | | CID | 5032 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain | | AID | 161 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID439794] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain [AID165, Type: other] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 439794 | | CID | 5032 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain | | AID | 165 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID443227] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice [AID248, Type: other] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 443227 | | CID | 5032 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 248 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID85789554] | Inactive | | | Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells [AID2275, Type: screening] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 85789554 | | CID | 5032 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells | | AID | 2275 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID85789554] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway [AID2313, Type: screening] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 85789554 | | CID | 5032 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway | | AID | 2313 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID85789554] | Inactive | | | Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity [AID2322, Type: screening] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 85789554 | | CID | 5032 | | Outcome | Inactive | | BioAssay | Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity | | AID | 2322 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID85789554] | Inactive | | | Fluorescence Cell-Based Primary HTS to Measure Inhibition of Y box Binding Protein 1 Expression [AID434959, Type: screening] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 85789554 | | CID | 5032 | | Outcome | Inactive | | BioAssay | Fluorescence Cell-Based Primary HTS to Measure Inhibition of Y box Binding Protein 1 Expression | | AID | 434959 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID74582] | Inconclusive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lewis Lung Carcinoma (subcutaneous) in B6D2F1 (BDF1) mice [AID270, Type: other] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 74582 | | CID | 5032 | | Outcome | Inconclusive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lewis Lung Carcinoma (subcutaneous) in B6D2F1 (BDF1) mice | | AID | 270 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|